VBI Vaccines Announces Completion of Sales Process to K2
CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ - VBI Vaccines Inc. ("VBI" or the "Company") today announced, that, in connection with its creditor protection proceedings under the Companies' Creditors Arrangement Act